Symbiotec Pharmalab Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- 385/2, Pigdamber, Rau, Mhow, Indore, Madhya Pradesh 453331, India (IND)
- Operations here
- api manufacture
- FDA identifiers
- FEI 3005122933 · DUNS 650328805
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-04-03
- VAIDrug Quality Assurance2019-10-22
- VAIDrug Quality Assurance2019-09-13
- VAIDrug Quality Assurance2017-05-12
- NAIDrug Quality Assurance2014-07-25
- NAIDrug Quality Assurance2012-01-20
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- betamethasone dipropionatePrimus Pharmaceuticals, Inc.
- clobetasol propionatePrimus Pharmaceuticals, Inc.
- Hydrocortisone sodium succinateCipla USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.